Novozymes A/S
F:NZM2
Novozymes A/S
F:NZM2
Price:
57.1
EUR
4.2%
Market Cap:
€23.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novozymes A/S
F:NZM2
|
DK |
|
Brookfield Corp
LSE:0KEH
|
CA |
|
C
|
Compagnie Financiere Richemont SA
F:RITN
|
CH |
|
C
|
Cigna Corp
XETRA:CGN
|
US |
|
TotalEnergies SE
PAR:TTE
|
FR |
|
H
|
Hmt Xiamen New Technical Materials Co Ltd
SSE:603306
|
CN |
|
A
|
Amgen Inc
XMUN:AMG
|
US |
|
B
|
Banco Santander SA
WSE:SAN
|
ES |
|
K
|
Kingspan Group PLC
XBER:KRX
|
IE |
|
C
|
Conocophillips
XBER:YCP
|
US |
|
N
|
Neste Oyj
SWB:NEF
|
FI |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
CN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of NZM2.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NZM2
Multiples-Based Value
Base Case
Not Available
